Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
Jérôme Barrière, Michel Carlès, Clarisse Audigier-Valette, Daniel Ré, Zoubir Adjtoutah, Barbara Seitz‐Polski, V. Gounant, Diane Descamps, Gérard Zalcman
Topics & Concepts
MedicineVaccinationImmunogenicityPopulationContext (archaeology)SerologyImmunityImmunologyIncidence (geometry)CancerDosingAntibodyObservational studyInternal medicineClinical trialImmune systemBiologyPhysicsEnvironmental healthOpticsPaleontologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy